Literature DB >> 25445030

Arginase inhibition enhances angiogenesis in endothelial cells exposed to hypoxia.

Lin Wang1, Anil Bhatta2, Haroldo A Toque2, Modesto Rojas3, Lin Yao2, Zhimin Xu3, Chintan Patel3, Ruth B Caldwell3, R William Caldwell4.   

Abstract

Hypoxia-induced arginase elevation plays an essential role in several vascular diseases but influence of arginase on hypoxia-mediated angiogenesis is completely unknown. In this study, in vitro network formation in bovine aortic endothelial cells (BAEC) was examined after exposure to hypoxia for 24h with or without arginase inhibition. Arginase activity, protein levels of the two arginase isoforms, eNOS, and VEGF as well as production of NO and ROS were examined to determine the involvement of arginase in hypoxia-mediated angiogenesis. Hypoxia elevated arginase activity and arginase 2 expression but reduced active p-eNOS(Ser1177) and NO levels in BAEC. In addition, both VEGF protein levels and endothelial elongation and network formation were reduced with continued hypoxia, whereas ROS levels increased and NO levels decreased. Arginase inhibition limited ROS, restored NO formation and VEGF expression, and prevented the reduction of angiogenesis. These results suggest a fundamental role of arginase activity in regulating angiogenic function.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Arginase; Endothelial cell; Endothelial nitric oxide synthase (eNOS); Reactive oxygen species (ROS)

Mesh:

Substances:

Year:  2014        PMID: 25445030      PMCID: PMC4361269          DOI: 10.1016/j.mvr.2014.11.002

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  45 in total

1.  Arginase II inhibition prevents nitrate tolerance.

Authors:  S M L Khong; K L Andrews; N N Huynh; K Venardos; A Aprico; D L Michell; M Zarei; K T Moe; G J Dusting; D M Kaye; J P F Chin-Dusting
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles.

Authors:  Naris Thengchaisri; Travis W Hein; Wei Wang; Xin Xu; Zhenbo Li; Theresa W Fossum; Lih Kuo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-06-22       Impact factor: 8.311

Review 3.  Recent advances in arginine metabolism: roles and regulation of the arginases.

Authors:  Sidney M Morris
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

4.  Role of arginase-2 and eNOS in the differential vascular reactivity and hypoxia-induced endothelial response in umbilical arteries and veins.

Authors:  B J Krause; C P Prieto; E Muñoz-Urrutia; S San Martín; L Sobrevia; P Casanello
Journal:  Placenta       Date:  2012-03-03       Impact factor: 3.481

5.  Arginase activity mediates retinal inflammation in endotoxin-induced uveitis.

Authors:  Wenbo Zhang; Babak Baban; Modesto Rojas; Sohrab Tofigh; Suvika K Virmani; Chintan Patel; M Ali Behzadian; Maritza J Romero; Robert W Caldwell; Ruth B Caldwell
Journal:  Am J Pathol       Date:  2009-07-09       Impact factor: 4.307

Review 6.  Oxygen-sensing under the influence of nitric oxide.

Authors:  Utta Berchner-Pfannschmidt; Suzan Tug; Michael Kirsch; Joachim Fandrey
Journal:  Cell Signal       Date:  2010-03       Impact factor: 4.315

7.  Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia.

Authors:  Sowndramalingam Sankaralingam; Han Xu; Sandra T Davidge
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787

Review 8.  The role of hypoxia-inducible factor 1 in atherosclerosis.

Authors:  Linggen Gao; Qian Chen; Xianliang Zhou; Li Fan
Journal:  J Clin Pathol       Date:  2012-05-08       Impact factor: 3.411

9.  Arginase inhibition mediates cardioprotection during ischaemia-reperfusion.

Authors:  Christian Jung; Adrian T Gonon; Per-Ove Sjöquist; Jon O Lundberg; John Pernow
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787

10.  Therapeutic Potential of the Nitrite-Generated NO Pathway in Vascular Dysfunction.

Authors:  Michael Madigan; Brian Zuckerbraun
Journal:  Front Immunol       Date:  2013-07-02       Impact factor: 7.561

View more
  10 in total

Review 1.  Arginase: an old enzyme with new tricks.

Authors:  Ruth B Caldwell; Haroldo A Toque; S Priya Narayanan; R William Caldwell
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

Review 2.  Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors.

Authors:  Khaled S Abdelkawy; Kelsey Lack; Fawzy Elbarbry
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

3.  Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability.

Authors:  Gustavo H Oliveira-Paula; Fernanda Borchers Coeli-Lacchini; Letícia Perticarrara Ferezin; Graziele C Ferreira; Lucas C Pinheiro; Waynice N Paula-Garcia; Luis V Garcia; Jose E Tanus-Santos; Riccardo Lacchini
Journal:  Eur J Clin Pharmacol       Date:  2021-01-07       Impact factor: 2.953

4.  Obesity-induced vascular inflammation involves elevated arginase activity.

Authors:  Lin Yao; Anil Bhatta; Zhimin Xu; Jijun Chen; Haroldo A Toque; Yongjun Chen; Yimin Xu; Zsolt Bagi; Rudolf Lucas; Yuqing Huo; Ruth B Caldwell; R William Caldwell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-08-23       Impact factor: 3.619

Review 5.  Arginase: A Multifaceted Enzyme Important in Health and Disease.

Authors:  R William Caldwell; Paulo C Rodriguez; Haroldo A Toque; S Priya Narayanan; Ruth B Caldwell
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

6.  Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.

Authors:  Anil Bhatta; Lin Yao; Zhimin Xu; Haroldo A Toque; Jijun Chen; Reem T Atawia; Abdelrahman Y Fouda; Zsolt Bagi; Rudolf Lucas; Ruth B Caldwell; Robert W Caldwell
Journal:  Cardiovasc Res       Date:  2017-11-01       Impact factor: 10.787

Review 7.  Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy?

Authors:  Esraa Shosha; Abdelrahman Y Fouda; S Priya Narayanan; R William Caldwell; Ruth B Caldwell
Journal:  J Clin Med       Date:  2020-02-05       Impact factor: 4.241

Review 8.  Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective.

Authors:  Gonçalo S Clemente; Aren van Waarde; Inês F Antunes; Alexander Dömling; Philip H Elsinga
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

Review 9.  Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective.

Authors:  Katharine L Bunch; Ammar A Abdelrahman; Ruth B Caldwell; R William Caldwell
Journal:  Front Physiol       Date:  2022-02-18       Impact factor: 4.566

Review 10.  Macrophage migration inhibitory factor (MIF) in the development and progression of pulmonary arterial hypertension.

Authors:  Mohamed Ahmed; Edmund Miller
Journal:  Glob Cardiol Sci Pract       Date:  2018-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.